Literature DB >> 11865435

Infection and nitric oxide.

John B Hibbs1.   

Abstract

The author describes how his experience as an infectious disease fellow at Stanford University with Jack Remington from 1969 to 1971 influenced the direction of his subsequent laboratory investigation. The author reviews a series of studies that were intended to provide a mechanistic understanding of an in vitro cytotoxicity assay developed while he was a fellow with Jack Remington. These investigations resulted in the 1987 discovery of the synthesis of nitric oxide from L-arginine by cytokine-activated macrophages. This work provided the components (the precursor, products, and an inhibitor) of the enzymatic synthesis of nitric oxide by all three later-identified nitric oxide synthase isoforms. The significance of cytokine-induced nitric oxide synthesis during innate resistance and cell-mediated immune reactions is discussed briefly.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11865435     DOI: 10.1086/338005

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

Review 1.  Thriving within the host: Candida spp. interactions with phagocytic cells.

Authors:  Pedro Miramón; Lydia Kasper; Bernhard Hube
Journal:  Med Microbiol Immunol       Date:  2013-01-25       Impact factor: 3.402

2.  Evaluation of tumorigenic potential of CeO2 and Fe2O3 engineered nanoparticles by a human cell in vitro screening model.

Authors:  Todd A Stueckle; Donna C Davidson; Raymond Derk; Tiffany G Kornberg; Diane Schwegler-Berry; Sandra V Pirela; Glen Deloid; Philip Demokritou; Sudjit Luanpitpong; Yon Rojanasakul; Liying Wang
Journal:  NanoImpact       Date:  2016-11-22

3.  Arginine homeostasis in J774.1 macrophages in the context of Mycobacterium bovis BCG infection.

Authors:  Meliza T Talaue; Vishwanath Venketaraman; Manzour Hernando Hazbón; Marcy Peteroy-Kelly; Anjali Seth; Roberto Colangeli; David Alland; Nancy D Connell
Journal:  J Bacteriol       Date:  2006-07       Impact factor: 3.490

4.  Nitric oxide synthase II suppresses the growth and metastasis of human cancer regardless of its up-regulation of protumor factors.

Authors:  Xiangdong Le; Daoyan Wei; Suyun Huang; Jack R Lancaster; Keping Xie
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-06       Impact factor: 11.205

5.  Imidazole antibiotics inhibit the nitric oxide dioxygenase function of microbial flavohemoglobin.

Authors:  Ryan A Helmick; Arin E Fletcher; Anne M Gardner; Christopher R Gessner; Angela N Hvitved; Michael C Gustin; Paul R Gardner
Journal:  Antimicrob Agents Chemother       Date:  2005-05       Impact factor: 5.191

6.  Elicitation of reactive oxygen species in Chlamydia pneumoniae-stimulated macrophages: a Ca2+-dependent process involving simultaneous activation of NADPH oxidase and cytochrome oxidase genes.

Authors:  Anthony A Azenabor; Shoua Yang; Godwin Job; Olanrewaju O Adedokun
Journal:  Med Microbiol Immunol       Date:  2005-01       Impact factor: 3.402

7.  Monocyte and interferon based therapy for the treatment of ovarian cancer.

Authors:  Daniel S Green; Ana T Nunes; Christina M Annunziata; Kathryn C Zoon
Journal:  Cytokine Growth Factor Rev       Date:  2016-03-15       Impact factor: 7.638

8.  Transcriptome analysis of murine macrophages in response to infection with Streptococcus pyogenes reveals an unusual activation program.

Authors:  Oliver Goldmann; Maren von Köckritz-Blickwede; Claudia Höltje; Gursharan S Chhatwal; Robert Geffers; Eva Medina
Journal:  Infect Immun       Date:  2007-05-25       Impact factor: 3.441

9.  Effect of macrophage classical (M1) activation on implant-adherent macrophage interactions with Staphylococcus epidermidis: A murine in vitro model system.

Authors:  Kyung R Park; James D Bryers
Journal:  J Biomed Mater Res A       Date:  2012-05-12       Impact factor: 4.396

Review 10.  Macrophage: SHIP of Immunity.

Authors:  Charles D Mills; Anita C Thomas; Laurel L Lenz; Markus Munder
Journal:  Front Immunol       Date:  2014-12-04       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.